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Abstract
Background: In the analysis of complex traits such as fasting plasma glucose levels, researchers
often adjust the trait for some important covariates before assessing gene susceptibility, and may
at times encounter confounding among the covariates and the susceptible genes. Previously, the
tree-based method has been employed to accommodate the heterogeneity in complex traits. In this
study, we performed a genome-wide screen on fasting glucose levels in the offspring generation of
the Framingham Heart Study provided by the Genetic Analysis Workshop 13. We defined one
quantitative trait and converted it to a dichotomous trait based on a predetermined cut-off value,
and performed association analyses using regression and classification trees for the two traits,
respectively. A marker was interpreted as positive if at least one of its alleles exhibited association
in both analyses. Our purpose was to identify candidate genes susceptible to fasting glucose levels
in the presence of other covariates. The covariates entered in the analysis including sex, body mass
index, and lipids (total plasma cholesterol, high density lipoprotein cholesterol, and triglycerides)
of the subjects, and those of their parents.
Results: Four out of seven positive regions in chromosomes 1, 2, 6, 11, 16, 18, and 19 from our
analyses harbored or were very close to previously reported diabetes related genes or potential
candidate genes.
Conclusion: This screen method that employed tree-based association showed promise for
identifying candidate loci in the presence of covariates in genome scans for complex traits.
Background
Problem 1 of Genetic Analysis Workshop 13 (GAW13)
provided the data from the Framingham Heart Study. We
focused on the offspring cohort due to the missing rate of
the data in the parental cohort.
Because the history of medical intervention, including the
adjustment of lifestyle and the use of anti-diabetic medi-
cations were not available, we chose the highest fasting
plasma glucose levels across the course of follow-up as the
targeted quantitative trait to indicate the potential risk for
abnormal glucose disposal. As suggested by the American
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Diabetes Association, the impaired fasting glucose (IFG,
fasting plasma glucose between 110 and 125 mg/dl)
appears as a risk factor for type 2 diabetes mellitus
(T2DM) [1]. We further used the lower limit of IFG (≥110
mg/dl) as the cut-off to transform this quantitative trait
into a dichotomy. In this way, we included the subjects in
the group with one or more incidences of higher fasting
plasma glucose. We then performed association analyses
using regression and classification trees for the two traits,
respectively. A marker was considered positive if at least
one of its alleles showed association in both analyses.
Our purpose was to identify candidate genes related to the
fasting glucose levels in the presence of covariates. We
found a few interesting markers that are closely linked
with some potential candidate genes biologically relevant
to glucose metabolism.
Method
Data processing
For the phenotype measurements, the corresponding cov-
ariates were created using their cross-sectional means. The
covariates entered in the analysis included sex, body mass
index, and lipids (total plasma cholesterol, high density
lipoprotein cholesterol, and triglycerides) for each sub-
jects. To control for potential familial correlations, the
cross-sectional means of the maternal and paternal phe-
notype measurements were also included as covariates.
For the genotypic data, an allele was chosen to enter the
analyses if its allele frequency is at least 10%. Alleles with
frequencies less than 10% but from the same marker are
categorized as an incognito allele. The allelic covariates
were created using the technique proposed by Zhang and
Bonney [2].
Association analysis using classification trees
The classification tree (CT) and regression tree (RT) meth-
ods are both built on the recursive partition technique;
they can be used to partition a study population into
homogeneous disjointed subgroups. The optimal tree is
created by both growing and pruning procedures. The
maximal tree is built by splitting each node into two child
nodes until the purity of the terminal node is achieved. In
splitting, the best choice of the child node is derived while
the minimum of the entropy impurity function is reached.
In pruning, it is processed for each binary class j in the
subtree  τ until the unconditional misclassification rate
 
is attained, where c(j|i) is the cost that a class j is classified
as a class i and IP is the entropy impurity function. In gen-
eral, choice of the cost depends on the severity of the mis-
classification. In this study, equal cost was chosen for both
misclassifications because it frequently gives most satis-
factory analyses [3], i.e., c(1|0) = c(0|1). The optimal tree
in RT is similar to that in CT with a different impurity
function
 , 
i.e., the within-node variance in the tree τ. More details of
CT, RT, and corresponding splitting criteria are described
elsewhere [3-5].
Tree-based association analysis was implemented by
using genotype measurements such as allelic covariates
and related phenotype measurements to construct binary
trees. An allele shows association with the trait if its corre-
sponding covariate is included in the optimal tree.
To illustrate the tree construction, a portion of an optimal
tree created by CT is presented in Figure 1. First, a total of
1667 subjects (the offspring generation) were divided into
two groups according to whether averaged BMI was less
than 26.35 or not (node 1 to nodes 2 and 8). Those with
averaged BMI higher than 26.35 were further subdivided
according to their HBP status (node 8 to nodes 9 and 15).
Those 314 subjects in node 9 were further divided into
node 10 (or 14) if their averaged maternal triglyceride was
lower (or higher) than 135.5 mg/dl. Finally, if the geno-
type was absent of allele 266 in D16S2620 then the sub-
ject was likely to have a fasting glucose levels lower than
110 mg/dl. In summary, allele 266 in D16S2620 was
associated with fasting glucose levels for those with higher
BMI (>26.35), no HBP, and lower maternal triglyceride
levels (<135.5 mg/dl).
Genome-wide screen
In this study, we conducted a genome-wide screen to iden-
tify the candidate gene in the presence of a set of specified
covariates. We performed RT- and CT-based association
analyses on the quantitative and dichotomy traits, respec-
tively. A marker was interpreted as positive if at least one
of its alleles showed association in both association anal-
yses. The allelic covariates from the same chromosome
were entered in the analyses simultaneously. The genome-
wide screen consisted of 22 such processes for the auto-
somes. The computer programs QUEST [6] and RT [7]
were used to construct the binary trees for the CT and RT
analyses.
Web-searching for candidate genes
The map position was defined using Ensemble Genome
Server at Sanger Institute http://www.ensembl.org/
Homo_sapiens/. For candidate gene search, we used
Online Medelian Inheritance in Man at National Center
for Biotechnology Information http://
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www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM or
euGene http://iubio.bio.indiana.edu:8089/man/.
Results
Table 1 shows these seven candidate regions, consisting of
nine positive markers in both analyses, were on chromo-
somes 1p, 2p, 6q, 11p, 16q, 18p, and 19q. Among these
seven regions, four regions, covering the four markers,
D1S1665, D6S474, D11S1981, and D19S254, were
closely linked to the genes previously reported to be rele-
vant to glucose metabolism or diabetes mellitus (details
listed in Table 1).
Discussions and Conclusions
In this study, the intent of our screen method was to iden-
tify candidate markers rather than to pinpoint susceptibil-
ity alleles, although it can be applied to detect the allelic
or non-allelic heterogeneity. The cut-off value used in CT
in this analysis was chosen for a biological reason. How-
ever, the analysis was sensitive to the choice of cut-offs
when the subjects were largely clustered around the cut-
A proportion of an optimal tree from classification tree Figure 1
A proportion of an optimal tree from classification tree Decision node criteria: 1. BMI: average BMI across-section 2. 
HBP: ever hypertension in all sections 3. MTG: average maternal triglycerides 4. Allele 266 of D16S2620 Definition of classes: 
Class 0, glucose levels < 110 mg/dl in all section; Class 1, at least one observed fasting glucose levels >110 mg/dl.Publish with BioMed Central    and   every 
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off point (>110 mg/dl). Only three regions on 1p, 16q,
and 18p were consistently positive at neighboring cut-offs
from 100 to 120.
Although covariates such as BMI and HBP, which are asso-
ciated with fasting glucose level, were included in our
analyses, the cut-off of these covariates in our final 22
optimal trees were not the same. Further studies are
needed to inspect the impact of different cut-off and asso-
ciated alleles.
From a different point of view, our method used the RT
analysis on the quantitative trait to validate the results
from CT such that the positive markers showed associa-
tion in both analyses. Notably, four out of the seven can-
didate regions harbored previously reported genes that are
related to glucose metabolism or diabetes mellitus. In
conclusion, our screen method shows promise for search-
ing candidate loci in genome scans for complex traits.
Acknowledgments
This study was partially supported by the National Science Council in Tai-
wan (NSC 91-3112-B-001-006-M51) and National Taiwan University Hos-
pital (NTUH-91A15).
References
1. The Expert Committee on the Diagnosis and Classification of Diabe-
tes Mellitus: Report of the Expert Committee on the Diagno-
sis and Classification of Diabetes Mellitus. Diabetes Care 1997,
20:1183-1197.
2. Zhang Z, Bonney GE: Use of classification trees for association
studies. Genet Epidemiol 2000, 19:323-332.
3. Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and
Regression Trees. New York, Chapman and Hall 1989.
4. Chang CJ, Fann CSJ: Using data mining to address heterogene-
ity in the Southampton data.  Genet Epidemiol 2001,
21:S180-S185.
5. Fann CSJ, Shugart YY, Lachman H, Collins A, Chang CJ: The impact
of redefining affection status for alcoholism on affected-sib-
pair analysis. Genet Epidemiol 1999, 17:S151-S156.
6. Department of Mathematics, National Chung Cheng
University,Taiwan:  Quest User Manual. Version 1.8.8.  Taiwan
2000.
7. Torgo L: RT 4.1 User's Manual. University of Porto, Porto, Portugal
2001.
Table 1: Positive markers found in the analyses using classification and regression trees
Chr Marker Marker Alias Position Previous Reports
1 D1S1665 GATA61A06 1p31.1 Amylase, salivary, Pancreatic (1p21), facilitated glucose transporter (1p31-35), 
agiopoietin-like 3 (1p31)
2 D2S2952 GATA116B01 2p25.1 Glucokinase regulatory protein (2p23), Alstrom syndrome (2p13), serum levels of leptin 
(2p21), hexokinase 2 (2p12), eukaryote translation initiation factor 2-α kinase 3 
(Wolcott-Rallison syndrome, 2p21)
6 D6S474 GATA31 6q21 IDDM 1 (6q21) IDDM5 (6q24-27), IDDM8 (6q25-27), IDDM15, transient neonatal 
diabetes mellitus (6q24), pleomorphic adenoma gene-like 1 (6q24-26), 
phosphodiesterase 1 (6q22-23)
11 D11S1981 GATA48E02 11p15.1 HRAS (11p14.1), INS (11p14.1), MODY1 (11p15.5), phosphodiesterase 3B (11p15), 
SUR1 (11p15.1), Kir6.2 (11p15.1)
16 D16S3396 ATA55A11 16q12.1 RRAD (16q22)
D16S3253 GATA22F09 16q12.2
D16S2620 GATA67G11
18 D18S542 GATA11A06 18p11.21
19 D19S254 Mfd238 19q13.43 Glycogen synthase 1 (muscle)(19q13.3), ApoCIII (19q13.2), Dystrophia Myotonica 1 
(19q13.2-13.3), AKT2 (19q13.1-13.2), TGFβ1 (19q13.1), Glycogen synthase kinase 3A 
(19q13.1-13.2)